Michihiro Yoshimi

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

Tomoya Kawaguchi, Masahiko Ando, Kazuhiro Asami et al. · Journal of Clinical Oncology · 2014 · 263 citations · Full text

Medicine, Oncology, Pharmacology +16

TGF-β1 as an Enhancer of Fas-Mediated Apoptosis of Lung Epithelial Cells

Naoki Hagimoto, Kazuyoshi Kuwano, Ichiro Inoshima et al. · The Journal of Immunology · 2002 · 198 citations

Life Sciences, Cell Biology, Pathobiology +15

The Role of High Mobility Group Box1 in Pulmonary Fibrosis

Naoki Hamada, Takashige Maeyama, Tomonobu Kawaguchi et al. · American Journal of Respiratory Cell and Molecular Biology · 2008 · 189 citations

Veterinary Medicine, Molecular Biology, Pathobiology +17

Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor

Kazuyoshi Kuwano, Ritsuko Kunitake, Takashige Maeyama et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2001 · 171 citations

Life Sciences, Immunology, Pathobiology +16

Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice

Naoki Hamada, Kazuyoshi Kuwano, Mizuho Yamada et al. · The Journal of Immunology · 2005 · 169 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17